Trials / Withdrawn
WithdrawnNCT03491865
Peer-to-peer Tobacco and ENDS Prevention
Peer-to-peer Social Media Diffusion of Tobacco and ENDS Use Prevention Messages
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Real Prevention, LLC · Industry
- Sex
- All
- Age
- 13 Years – 16 Years
- Healthy volunteers
- Accepted
Summary
In Phase I, the REAL media Plus prototype will be developed and a usability test conducted among students and teachers. In Phase II a group randomized trial will be conducted among 27 high schools to evaluate the effects of REAL media Plus on smoking and vaping.
Detailed description
In Phase I, participants will participate in pilot and usability tests of the curriculum prototype. For the pilot test, teachers and students will use the curriculum prototype and then be interviewed about it. For the usability test, students and teachers will use the revised curriculum and be interviewed/complete short survey. Teachers will provide consent and students will have parental consent and their own assent. In Phase II, a group randomized trial will be conducted during Spring semester 2020 among 9th grade student in 27 high schools in the Hillsborough County Public School system randomly assigned to treatment and control (14 treatment and 13 control). All students will complete a pretest survey. Students in two health classes in treatments schools will participate in the REAL media Plus curriculum and complete a short immediate posttest survey to rate their experience. All students will then complete two posttests. Students will have parental consent and provide their own assent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | REAL media Plus curriculum | REAL media Plus is a 7-level, interactive, self-paced, e-learning media literacy curriculum to prevent youth smoking and vaping use. |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2021-05-31
- Completion
- 2021-05-31
- First posted
- 2018-04-09
- Last updated
- 2019-09-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03491865. Inclusion in this directory is not an endorsement.